Oncology Procedures

Cyclic cytotoxic chemotherapy using cell-killing drugs to destroy rapidly dividing cancer cells throughout the body. Treatment given in 21-28 day cycles allows recovery between sessions, with 4-8 cycles over 3-6 months depending on cancer type and response. Thailand offers 50-70% cost savings with JCI-accredited facilities using identical NCCN-guideline protocols.

Revolutionary cancer treatment using immune checkpoint inhibitors (ICIs) that harness the body's immune system to recognize and attack cancer cells by blocking proteins like PD-1, PD-L1, and CTLA-4.

Minimally invasive surgery using the da Vinci Xi robotic system with 3D HD visualization, 10x magnification, and 7-degree EndoWrist instruments for precise tumor removal with 44% fewer complications than open surgery.

Potentially curative transplantation of healthy hematopoietic stem cells to replace damaged bone marrow, treating blood cancers like leukemia and lymphoma, bone marrow failure syndromes, and certain genetic diseases.

Genetically engineered immune cells (CAR-T) that target and destroy cancer cells, offering 80-90% remission rates for eligible blood cancer patients per CIBMTR registry data. Thailand facilities report significant cost savings compared to US treatment.

Surgical removal of part or all of the colon for colorectal cancer treatment. Thailand offers 50-80% cost savings with da Vinci Xi robotic-assisted surgery, laparoscopic techniques at JCI-accredited facilities, and Enhanced Recovery After Surgery (ERAS) protocols for faster recovery.

Non-invasive robotic radiosurgery delivering high-dose radiation with sub-millimeter accuracy. A leading platform for frameless stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) with continuous real-time tumor tracking. Treatment completed in 1-5 sessions vs 25-40 with conventional radiation.

Cytoreductive surgery combined with heated chemotherapy (41-43°C) delivered directly into the abdominal cavity for peritoneal cancers. Thailand typically offers 50-80% cost savings versus US hospital charges at confirmed HIPEC programs including Vejthani Hospital, with specialized multidisciplinary teams and JCI-accredited facilities.

Advanced external beam radiation using computer-controlled linear accelerators with multileaf collimators to precisely shape radiation beams to tumor contour, enabling dose escalation while sparing healthy tissue. Thailand offers treatment at 50-80% lower cost than US.

Breast-conserving surgery removing tumor while preserving breast shape through combined oncologic and plastic surgery techniques. Thailand offers 50-70% cost savings with advanced oncoplastic approaches, dual-trained surgeons, and JCI-accredited facilities achieving equivalent survival to mastectomy for early-stage breast cancer.

Surgical removal of breast tissue for breast cancer treatment or prevention. Thailand offers 60-80% cost savings with oncoplastic surgery combining removal with cosmetic reconstruction, BRCA genetic testing, and JCI-accredited facilities with experienced breast surgeons.

Surgical removal of kidney (radical) or kidney tumor (partial/nephron-sparing) for renal cell carcinoma and other kidney cancers, with laparoscopic and robotic options available at Thailand's JCI-accredited hospitals.

Advanced diagnostic imaging combining metabolic (PET) and anatomic (CT/MRI) scans to detect cancer spread, monitor treatment response, and guide oncology treatment planning with exceptional accuracy.

Advanced particle radiation using protons instead of X-rays, delivering precise tumor doses via the Bragg peak while sparing surrounding tissue. Achieves 66% reduction in Grade 3+ side effects compared to conventional photon radiation.

Surgical removal of the prostate gland and surrounding tissue for treatment of localized prostate cancer, with open, laparoscopic, or robot-assisted (da Vinci) approaches offering 85-95% 5-year biochemical control rates.

Minimally invasive surgical staging procedure identifying the first lymph node(s) to which cancer cells spread from primary tumors. Thailand offers 60-70% cost savings with dual-tracer technique achieving 95%+ identification rates, JCI-accredited facilities with nuclear medicine capabilities, and multidisciplinary tumor boards at Bumrungrad, Bangkok Hospital, and MedPark.

Catheter-based delivery of chemotherapy directly to liver tumors while blocking blood supply; minimally invasive treatment for hepatocellular carcinoma with 70-85% cost savings vs US

Precision cancer treatment using drugs that target specific molecular alterations in cancer cells, including tyrosine kinase inhibitors (TKIs), monoclonal antibodies, and antibody-drug conjugates for patients with actionable biomarkers.

Surgical removal of thyroid gland for cancer treatment. Includes total thyroidectomy, hemithyroidectomy, and minimally invasive options including da Vinci robotic and scarless transoral (TOETVA) approaches. Near 100% 5-year survival for differentiated thyroid cancers with 40-75% cost savings in Thailand.

Video-assisted thoracoscopic surgery to remove a cancerous lung lobe through small incisions. Minimally invasive approach offers faster recovery and less pain than open thoracotomy for early-stage non-small cell lung cancer.